Additionally, glioma cells produce numerous anti-inflammatory cytokines (e.g., IL-10, IL-6, TGF-β2, PGE2) that can revert activated microglia to an anti-inflammatory phenotype (Hishii et al., 1995; Pyonteck et al., 2013). This evidence concerns the gene TGFB2 and central nervous system cancer.